Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutamate ionotropic receptor kainate type (KAR) is a class of ligand-gated ion channels that mediate excitatory neurotransmission in the central nervous system (UniProt: P39086). Composed of various combinations of five subunits (GluK1-GluK5), these receptors are distinct from AMPA and NMDA receptors in their kinetics and physiological roles (Lerma & Marques, Neuron, 2013). KARs function both postsynaptically to mediate excitatory currents and presynaptically to modulate the release of other neurotransmitters like GABA and glutamate (IUPHAR/BPS Guide to Pharmacology, 2023). They play a critical role in synaptic plasticity and the regulation of neuronal circuit excitability. Dysregulation of KAR signaling is implicated in several neurological and psychiatric conditions, including epilepsy, neuropathic pain, and schizophrenia (Jane et al., British Journal of Pharmacology, 2009). Consequently, KARs are significant therapeutic targets, with research focusing on subunit-specific antagonists to treat hyperexcitability disorders without the side effects associated with broad-spectrum glutamate inhibition (StatPearls, 2023).
Ligand-gated ion channel activation or inhibition; drugs act as agonists, antagonists, or non-competitive modulators to regulate cation flux (Na+ and K+) across the neuronal membrane (IUPHAR/BPS Guide to Pharmacology, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate ionotropic receptor kainate type (KAR) (KAR).